Análisis Argos
GEHC
GEHCEn su precio1 señal de riesgo
GE HealthCare Technologies Inc. · Healthcare
US$ 65.57
precio al 2026-07-04
Valor justo Argos*
US$ 46–55
vs. su valor justo
31% por encima
Score Argos
35/100
En su precio
LA RESPUESTA
El precio asume un crecimiento (12.7%) en línea con lo que la empresa demuestra (7.4%). Ni ganga ni exceso — el mercado le puso un precio razonable.
Recompensas
Sin recompensas destacadas.
Riesgos
!Cotiza 26% por encima de su valor justo.
!Balance frágil: la deuda pesa sobre el negocio.
!Crecimiento estancado o en baja.
!Piotroski F-Score débil (3/9)
VALOR3/6FUTURO2/6PASADO3/6SALUD2/6DIVIDENDO2/6
El Iris de calidad
VALOR3/6FUTURO2/6PASADO3/6SALUD2/6DIVIDENDO2/6
ValorCerca de su valor justo
FuturoCrecimiento moderado
PasadoHistorial aceptable
SaludBalance razonable
DividendoRetorno al accionista moderado
Score Argos35de 100En su precio
Ingresos5%
US$ 20.6 B
Margen operativo1%
13.4%
Flujo de caja libre3%
US$ 1.5 B
Deuda neta
US$ 5.5 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 29.8B
P/E14.3x
EV/EBITDA10.6x
FCF yield5%
ROIC13.5%
Margen operativo13.4%
Crecim. ingresos+4.8%/año
Piotroski F3/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

businesswire.com · 30 jun
GE HealthCare announces cash dividend for second quarter of 2026
CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the second quarter of 2026 payable on August 14, 2026, to all shareholders of record as of July 24, 2026.About GE HealthCare Technologies Inc.GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle.
zacks.com · 30 jun
GEHC Launches Allia Upgrade Pathways for Interventional Suites
GE HealthCare's Allia upgrade pathways let providers modernize legacy imaging systems with AI-enabled workflows while reducing construction and disruption.
businesswire.com · 29 jun
GE HealthCare introduces Allia upgrade pathways designed to modernize existing interventional suites
CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced Allia™ platform upgrade pathways designed to help customers modernize select legacy Innova™ and Discovery™ Image Guiding Solutions (IGS) systems. These pathways provide access to Allia technologies and workflows that support efficiency and procedural decision-making while helping preserve existing infrastructure, avoid major construction work, extend interventional room lifetime, and minimize disruption to clinical operations. As procedura.
247wallst.com · 23 jun
Here Are Tuesday's Best Wall Street Analyst Research Calls: Centene, Darden Restaurants, Flutter Entertainment, GE Healthcare, IBM, Nike, SpaceX, Synopsys, Target, and More
Futures are trading lower after a mixed start to trading on Monday, following the holiday-shortened week due to the Juneteenth Federal holiday.
zacks.com · 15 jun
GEHC Expands Carilion Tie to Enhance Patient Care Across Virginia
GE HealthCare expands its Carilion Clinic collaboration with AAMP and Encompass to improve equipment management and operational efficiency across Virginia.
businesswire.com · 9 jun
GE HealthCare advancing enterprise imaging with cloud-enabled solutions
CHICAGO--(BUSINESS WIRE)--GE HealthCare will showcase its latest enterprise imaging solutions at the Society for Imaging Informatics in Medicine (SIIM) 2026 Annual Meeting in Pittsburgh, PA. Medical imaging departments today are under immense pressure from all sides including rising imaging volumes and increasing case complexity, while staffing shortages continue to grow. According to the American College of Radiology (ACR), radiologist workforce shortages have been identified as the biggest th.
zacks.com · 5 jun
GE HealthCare Gains FDA Clearance for AI Radiation Planning Software
GEHC wins FDA clearance for AI-powered radiation planning software, adding new clinical models and a pathway for faster future updates.
businesswire.com · 4 jun
GE HealthCare receives FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, advancing AI-enabled radiation therapy planning with expanded clinical capabilities
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for MIM Contour ProtégéAI+™ 2.0, an AI-enabled auto-contouring software to assist radiation oncology care teams with treatment planning. This can help clinicians reduce treatment planning time, enabling them to focus on delivering more timely and personalized care for patients. The FDA clearance includes a Predetermined Change Control.

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.